Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Health technology assessment/appraisal (HTA)
A review of the evidence (usually a systematic review) on the impact of a healthcare intervention (or 'technology'), often including economic evaluation evidence as in the case of the National Institute of Health and Clinical Excellence (NICE).
See also:
National Institute of Health and Clinical Excellence (NICE)
Related terms
Cost-effectiveness analysis (health economics), Health Status Index, Cost-effectiveness (in media/advertising), Prescribing information, Defined daily dose (DDD), National Institute for Health and Clinical Excellence , Dog, Interventions - clinical, Cost utility analysis (health economics), Healthy years equivalent (HYE), Economic evaluation, International Clinical Trial Registry Platform (ICTRP), e-Detailing, Prophylaxis, European Association of Communications Agencies (EACA),
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- AstraZeneca joins UK pilot evaluating AI-based lung cancer diagnosis system
- Alzheimer’s Society urges UK government to deliver on dementia plan
- Amgen announces positive results for Lumakras colorectal cancer combination treatment
- BeiGene’s Brukinsa granted two new marketing authorisations by MHRA
- Navigating the patient experience to improve retention of clinical trial participants
- Europe’s cancer community publishes new report on transforming patient care
- Alzheimer’s Research UK welcomes government’s pledge to tackle dementia crisis
- Eli Lilly announces $450m investment in US manufacturing site
- Pistoia Alliance launches free guide on implementing FAIR principles in clinical data
- World Health Organization launches $2.54bn emergency health appeal
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- EU to revise pharmaceuticals law amid antibiotic shortages
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Why everyone in pharma is bending over backwards to be agile
